Literature DB >> 8171279

Nonopsonic activation of neutrophils and cytotoxin production by Helicobacter pylori: ulcerogenic markers.

H Rautelin1, B Blomberg, G Järnerot, D Danielsson.   

Abstract

Fifty-four clinical isolates of Helicobacter pylori from human gastric biopsy specimens were tested for cytotoxin production, as determined by intracellular vacuolization of HeLa cells, and for the induction of oxidative burst in human polymorphonuclear leukocytes (PMNLs), as measured by luminol-enhanced chemiluminescence (CL). Nonopsonized, 20 of the H. pylori strains induced a rapid and strong CL response, in contrast to 30 other strains, which showed only weak and slow responses. Another four strains gave inconclusive results. Cytotoxin production was demonstrated in 10 of the 20 strains with rapid responses but only in 3 of the 30 strains with slow and low responses (p = 0.0027, Fisher's exact test, two-tailed). Eleven of the 15 cytotoxin-producing strains (p = 0.0135) and 13 of the 20 strains with strong CL responses (p = 0.0209) were from 22 patients with peptic ulcer disease (PUD). The ability of some nonopsonized H. pylori to activate PMNLs showed co-variation with their ability to produce cytotoxin, but these two properties seem to be independent markers of PUD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8171279     DOI: 10.3109/00365529409090450

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  8 in total

1.  Nonopsonic binding of type III Group B Streptococci to human neutrophils induces interleukin-8 release mediated by the p38 mitogen-activated protein kinase pathway.

Authors:  E A Albanyan; J G Vallejo; C W Smith; M S Edwards
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

2.  Co-expression in Helicobacter pylori of cagA and non-opsonic neutrophil activation enhances the association with peptic ulcer disease.

Authors:  D Danielsson; S M Farmery; B Blomberg; S Perry; H Rautelin; J E Crabtree
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

Review 3.  The clinical relevance of strain types of Helicobacter pylori.

Authors:  J C Atherton
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

4.  Cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis.

Authors:  H Rautelin; B Blomberg; H Fredlund; G Järnerot; D Danielsson
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

5.  Genotypic and phenotypic stability of Helicobacter pylori markers in a nine-year follow-up study of patients with noneradicated infection.

Authors:  Anders Gustavsson; Magnus Unemo; Björn Blomberg; Dan Danielsson
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

6.  Serologic detection of infection with cagA+ Helicobacter pylori strains.

Authors:  T L Cover; Y Glupczynski; A P Lage; A Burette; M K Tummuru; G I Perez-Perez; M J Blaser
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

7.  Modulating phagocyte activation: the pros and cons of Helicobacter pylori virulence factors.

Authors:  L A Allen
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

8.  Kingella kingae Surface Polysaccharides Promote Resistance to Neutrophil Phagocytosis and Killing.

Authors:  Vanessa L Muñoz; Eric A Porsch; Joseph W St Geme
Journal:  mBio       Date:  2019-06-25       Impact factor: 7.867

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.